Article
Influence of DNA repair RAD51 gene variants in overall survival of non-small cell lung cancer patients treated with first line chemotherapy.
Cancer chemotherapy and pharmacology - 1 Aug 2010
Nogueira Augusto, Catarino Raquel, Coelho Ana, Araújo António, Gomes Mónica, Medeiros Rui
Abstract excerpt
PURPOSE: Lung cancer continues to be the most frequent cancer with approximately one million people worldwide dying of this disease each year. Non-small-cell lung cancer (NSCLC) accounts for approximately 80% of all lung cancers. The RAD51 protein is the key protein for homologous recombination,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
